Leica Biosystems continues to closely monitor the COVID-19 pandemic and its impact on our business. The health and well-being of our associates, customers and partners is our top priority. We want you to know that we are here for you during this time.
Supply Continuity and Service
We are actively keeping track of and managing our business continuity plan to ensure that our customers have access to the products they need to help patients. We are taking every step possible to mitigate any impact from the virus on our supply chain.
Currently, all our production sites are operational. We are closely following guidance from international health organizations and local governments to ensure the safety of our associates as they continue to produce essential product.
Our Service associates are following our business continuity plans to ensure the safety of their customers and teammates. They will follow all customer protocols related to personal protective equipment aligned with CDC and WHO site risk levels.
We will continue to monitor the situation in the coming days and weeks. If you require further detail about product supply, please reach out to your Leica Biosystems representative or visit the Contact Us page on our website.
Event and Conference Participation
In light of the COVID-19 pandemic, we have made the difficult decision to cancel our participation in all face-to-face tradeshows and industry events until further notice. We will communicate about future virtual event opportunities via email.
Leica Biosystems Site Visitor Guidance
We are following guidelines from international health organizations, local governments and our parent company, Danaher, to minimize risk of exposure at our global sites. You may be required to complete a form before you visit a Leica Biosystems facility and some of our sites may be restricting visitors entirely for the continued safety of our associates. Please reach out to your local contact for more information.